JPM vs NMI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NMI exhibits a stable but stagnant financial profile with a Piotroski F-Score of 5/9, yet it faces significant valuation and sustainability headwinds. The fund is trading at a substantial premium to its Graham Number ($7.90) and Intrinsic Value ($1.96), while the technical trend is completely bearish (0/100). Most critically, the dividend payout ratio of 162.86% indicates that the current yield is unsustainable and likely being funded by capital rather than earnings. With earnings growth declining by 19.10% YoY, the fund lacks the fundamental momentum to justify its current price.
Compare Another Pair
Related Comparisons
JPM vs NMI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Nuveen Municipal Income Fund, Inc. (NMI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.